Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:39:58.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous downtime notice (Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:53:31.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding/status notice and updated the page version to Revision 3.4.1, replacing 3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:52:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated labels: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed older label variations ('Last Update Submitted that met QC Criteria', 'No FEAR Act data') and the previous revision ('v3.3.4').
    Difference
    0.2%
    Check dated 2026-01-28T07:51:08.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T03:26:47.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing a recruitment site in Philadelphia, PA, United States. Updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:31:43.000Z thumbnail image

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.